Early postoperative complications and local relapses after nipple sparing mastectomy and immediate breast reconstruction using silicone implants

Q4 Medicine

Archive of Oncology Pub Date : 2019-01-01 DOI:10.2298/AOO180701008S

V. Selaković, M. Ranisavljevic, Z. Radovanovic, F. Vicko, D. Lukić, Mladen Ðuric

{"title":"Early postoperative complications and local relapses after nipple sparing mastectomy and immediate breast reconstruction using silicone implants","authors":"V. Selaković, M. Ranisavljevic, Z. Radovanovic, F. Vicko, D. Lukić, Mladen Ðuric","doi":"10.2298/AOO180701008S","DOIUrl":null,"url":null,"abstract":"Purpose: Purpose of this study was to evaluate early complications and risk factors associated with nipple sparing mastectomy and immediate breast reconstruction. Methods: This retrospective study was made using data from 246 breast cancer patients treated at the Oncology Institute of Vojvodina in the period from January 2010 to December 2015. In all patients nipple sparing mastectomy was performed along with primary breast reconstruction. Results: The mean indication for nipple sparing mastectomy was multicentricity of the tumor (114 patients; 46.3%). The majority of surgically treated patients were in stage II of the disease. The total percentage of local relapses after the nipple sparing mastectomy was 1.6% (4 patients). Total percentage of early complications was 15% (37 patients). Median follow-up after nipple sparing mastectomy was 260 weeks (ranging from 417 to 104 weeks). Conclusion: Primary reconstruction of the breasts using heterologous implants is standard surgical procedure for breast cancer that does not lead to increased number of complications, nor to increased percentage of the local recurrence.","PeriodicalId":35645,"journal":{"name":"Archive of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archive of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2298/AOO180701008S","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 2

Abstract

Purpose: Purpose of this study was to evaluate early complications and risk factors associated with nipple sparing mastectomy and immediate breast reconstruction. Methods: This retrospective study was made using data from 246 breast cancer patients treated at the Oncology Institute of Vojvodina in the period from January 2010 to December 2015. In all patients nipple sparing mastectomy was performed along with primary breast reconstruction. Results: The mean indication for nipple sparing mastectomy was multicentricity of the tumor (114 patients; 46.3%). The majority of surgically treated patients were in stage II of the disease. The total percentage of local relapses after the nipple sparing mastectomy was 1.6% (4 patients). Total percentage of early complications was 15% (37 patients). Median follow-up after nipple sparing mastectomy was 260 weeks (ranging from 417 to 104 weeks). Conclusion: Primary reconstruction of the breasts using heterologous implants is standard surgical procedure for breast cancer that does not lead to increased number of complications, nor to increased percentage of the local recurrence.

查看原文本刊更多论文

保留乳头乳房切除术及硅胶即刻乳房重建术后早期并发症及局部复发

目的:本研究的目的是评估保留乳头乳房切除术和立即乳房重建的早期并发症和危险因素。方法:本回顾性研究采用2010年1月至2015年12月在伏伊伏丁那肿瘤研究所接受治疗的246例乳腺癌患者的数据。所有患者均行保留乳头乳房切除术及乳房重建。结果:保留乳头乳房切除术的平均指征为肿瘤多中心性(114例;46.3%)。大多数接受手术治疗的患者处于疾病的II期。保留乳头乳房切除术后局部复发的总比例为1.6%(4例)。早期并发症的总比例为15%(37例)。保留乳头乳房切除术后的中位随访时间为260周(从417周到104周)。结论:采用异体假体一期乳房重建是治疗乳腺癌的标准手术方法，不会增加并发症的数量，也不会增加局部复发率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archive of Oncology Medicine-Oncology

CiteScore

0.60

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： Archive of Oncology is an international oncology journal that publishes original research, editorials, review articles, case (clinical) reports, and news from oncology (medical, surgical, radiation), experimental oncology, cancer epidemiology, and prevention. Letters are also welcomed. Archive of Oncology is covered by Biomedicina Vojvodina, Biomedicina Serbica, Biomedicina Oncologica, EMBASE/Excerpta Medica, ExtraMED and SCOPUS.